XML 36 R17.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

Taxation | 12 Months Ended
--- | ---
Dec. 31, 2023
Taxation [Abstract] |
TAXATION | 10. TAXATION
|  | Year Ended December 31, |
|  | 2023 $’000 |  |  | 2022 $’000 |  |  | 2021 $’000 |
Group |  |  |  |  |  |  |  |  |
Current year tax (credit) |  |  | 449 |  |  |  | - |  |  |  | (3,255 | )
Adjustments due to prior periods |  |  | - |  |  |  | - |  |  |  | (15 | )
Total tax (credit) for the period |  |  | 449 |  |  |  | - |  |  |  | (3,240 | )
The tax charge for the year is different from the standard rate of corporation tax in the United Kingdom of 19%. The difference can be reconciled as follows: |  |  |  |  |  |  |  |  |  |  |  |
Loss before taxation |  |  | (17,242 | ) |  |  | (15,397 | ) |  |  | (26,657 | )
Loss charged at standard rate of corporation tax 23.52% 2023 19%2021/22 |  |  | (4,055 | ) |  |  | (2,926 | ) |  |  | (5,065 | )
Movement in unrecognized deferred tax |  |  | 3,194 |  |  |  | 2,319 |  |  |  | 1,722 |
Expenses not deductible for taxation |  |  | 3,961 |  |  |  | 1,036 |  |  |  | 1,550 |
Adjustments due to prior periods |  |  | 449 |  |  |  | - |  |  |  | (15 | )
Research and development claim |  |  | - |  |  |  | - |  |  |  | (1,401 | )
Income not taxable for tax purposes |  |  | (3,113 | ) |  |  | (495 | ) |  |  | (61 | )
Fixed asset differences |  |  | - |  |  |  | (1 | ) |  |  | - |
Current Tax - Other |  |  | 13 |  |  |  | - |  |  |  | - |
Adjustments to brought forward values |  |  | - |  |  |  | 67 |  |  |  | - |
Consolidation adjustment in relation to foreign exchange movements |  |  | - |  |  |  | - |  |  |  | - |
|  |  | 449 |  |  |  | - |  |  |  | (3,240 | )
The Research and Development claim has been calculated in accordance with the R&D tax relief available to small and medium sized entities, whereby the entity is able to claim a cash tax credit (if loss making), worth up to 14.5% of the surrenderable losses. The adjustments due to prior periods relate to R&D tax relief claims for the prior period. Under UK tax legislation, a 2-year window is available under which R&D tax relief can be claimed. No deferred tax asset has been recognized in respect of trading losses carried forward because of uncertainty as to when these losses will be recoverable. The amount of tax losses for which no deferred tax assets have been recognized for the year ended December 31, 2023 is $18,137k (2022 is $15,011k; 2021; $11,591k).

X
- Definition The entire disclosure for income taxes. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 12 -IssueDate 2023-01-01 -Section Disclosure -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI -URIDate 2023-03-23 + Details
Name: | ifrs-full_DisclosureOfIncomeTaxExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | tlsa_TaxationAbstract
Namespace Prefix: | tlsa_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration